Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 9:50 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC. RYTM | PERCEPTIVE ADVISORS LLC | 5,435,210 8.600% | 291,635 (+5.67%) | View |
| 2024-11-14 8:14 pm Purchase | 13G | INHIBRX BIOSCIENCES INC INBX | PERCEPTIVE ADVISORS LLC | 1,488,553 9.900% | 1,488,553 (New Position) | View |
| 2024-11-14 7:59 pm Purchase | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% | 6,934,678 (New Position) | View |
| 2024-11-14 5:26 pm Unchanged | 13D | TRINITY BIOTECH PLC TRIB | PERCEPTIVE ADVISORS LLC | 56,000,000 22.600% | 0 (Unchanged) | View |
| 2024-11-14 4:50 pm Purchase | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 1,869,219 9.900% | 474,503 (+34.02%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | IOVANCE BIOTHERAPEUTICS INC. IOVA | PERCEPTIVE ADVISORS LLC | 26,617,709 8.800% | 7,395,966 (+38.48%) | View |
| 2024-11-14 4:50 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | PERCEPTIVE ADVISORS LLC | 2,812,665 3.800% | -1,209,401 (-30.07%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | ALDEYRA THERAPEUTICS, INC ALDX | PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% | 682,265 (+7.94%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | PERCEPTIVE ADVISORS LLC | 426,293 5.900% | 426,293 (New Position) | View |
| 2024-11-14 4:50 pm Purchase | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% | 1,447,788 (+28.29%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | Nuvalent Inc. NUVL | PERCEPTIVE ADVISORS LLC | 2,979,235 4.600% | 61,244 (+2.10%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | EVOLUS INC EOLS | PERCEPTIVE ADVISORS LLC | 5,356,622 8.500% | 1,393,198 (+35.15%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | PERCEPTIVE ADVISORS LLC | 10,005,000 8.500% | 5,424,751 (+118.44%) | View |
| 2024-11-14 4:50 pm Sale | 13G | INHIBRX BIOSCIENCES INC INBX | PERCEPTIVE ADVISORS LLC | 0 0.000% | -4,776,306 (Position Closed) | View |
| 2024-11-14 4:41 pm Unchanged | 13D | ASTRIA THERAPEUTICS INC ATXS | PERCEPTIVE ADVISORS LLC | 6,485,420 11.500% | 0 (Unchanged) | View |
| 2024-11-14 4:33 pm Purchase | 13G | Spyre Therapeutics Inc. SYRE | PERCEPTIVE ADVISORS LLC | 2,872,547 5.700% | 265,868 (+10.20%) | View |
| 2024-11-14 4:31 pm Purchase | 13G | FORTE BIOSCIENCES INC FBRX | PERCEPTIVE ADVISORS LLC | 151,433 9.990% | 151,433 (New Position) | View |
| 2024-11-14 4:31 pm Sale | 13G | Arcellx Inc. ACLX | PERCEPTIVE ADVISORS LLC | 3,888,669 7.200% | -656,140 (-14.44%) | View |
| 2024-11-14 4:31 pm Unchanged | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | PERCEPTIVE ADVISORS LLC | 12,594,211 10.000% | 0 (Unchanged) | View |
| 2024-11-14 4:30 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 3,454,976 8.800% | 380,434 (+12.37%) | View |